Charles River Labs (CRL) PT Lowered to $275 at Baird
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $181.57 -1.85%
Rating Summary:
22 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
22 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Baird analyst Eric W. Coldwell lowered the price target on Charles River Labs (NYSE: CRL) to $275.00 (from $277.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Charles River Labs (CRL) to Overweight, 'strong uptick in biopharma funding beginning to transition into RFPs and bookings'
- Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
- Macy's (M) PT Raised to $25 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
